返回 Agenda
Session 6: The Impact of the Global Pandemic on Healthcare Project Managers
Session Chair(s)
Karla Childers, MS
Head, Bioethics-Based Science and Technology Policy
Johnson & Johnson, United States
In this session, we will explore how healthcare PMs and their teams tackled the challenges brought about by the pandemic to non-COVID projects. While a great deal of attention has been paid to the impact of COVID-19, the need to continue to deliver life saving medicines, medical devices, and healthcare services, in general, did not go away.
Learning Objective : Upon completion of this session, the participant should be able to:
- Identify key lessons from the experiences of PMs who had to pivot and evolve their projects as a result of the pandemic
- Explain how the ability to adapt and pivot can be applied beyond global public health emergencies
- Apply these concepts to their own projects
Speaker(s)
Speaker
Jeremy Baker, MBA, PMP
Eli Lilly & Co., United States
Pharma Project Management
Speaker
Gina Chevalier, MS, PMP
Johnson & Johnson, United States
Senior Manager Strategic Projects, Office of the Chief Medical Officer